位置:首页 > 蛋白库 > ASAH1_PANTR
ASAH1_PANTR
ID   ASAH1_PANTR             Reviewed;         395 AA.
AC   A5A6P2;
DT   16-JUN-2009, integrated into UniProtKB/Swiss-Prot.
DT   12-JUN-2007, sequence version 1.
DT   03-AUG-2022, entry version 76.
DE   RecName: Full=Acid ceramidase {ECO:0000305};
DE            Short=AC;
DE            Short=ACDase;
DE            Short=Acid CDase;
DE            EC=3.5.1.23 {ECO:0000250|UniProtKB:Q13510};
DE   AltName: Full=Acylsphingosine deacylase;
DE   AltName: Full=N-acylethanolamine hydrolase ASAH1 {ECO:0000250|UniProtKB:Q13510};
DE            EC=3.5.1.- {ECO:0000250|UniProtKB:Q13510};
DE   AltName: Full=N-acylsphingosine amidohydrolase;
DE   Contains:
DE     RecName: Full=Acid ceramidase subunit alpha {ECO:0000250|UniProtKB:Q13510};
DE   Contains:
DE     RecName: Full=Acid ceramidase subunit beta {ECO:0000250|UniProtKB:Q13510};
DE   Flags: Precursor;
GN   Name=ASAH1 {ECO:0000250|UniProtKB:Q13510};
OS   Pan troglodytes (Chimpanzee).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Pan.
OX   NCBI_TaxID=9598;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Subsp. verus; TISSUE=Skin;
RX   PubMed=17574350; DOI=10.1016/j.gene.2007.04.013;
RA   Sakate R., Suto Y., Imanishi T., Tanoue T., Hida M., Hayasaka I.,
RA   Kusuda J., Gojobori T., Hashimoto K., Hirai M.;
RT   "Mapping of chimpanzee full-length cDNAs onto the human genome unveils
RT   large potential divergence of the transcriptome.";
RL   Gene 399:1-10(2007).
CC   -!- FUNCTION: Lysosomal ceramidase that hydrolyzes sphingolipid ceramides
CC       into sphingosine and free fatty acids at acidic pH (By similarity).
CC       Ceramides, sphingosine, and its phosphorylated form sphingosine-1-
CC       phosphate are bioactive lipids that mediate cellular signaling pathways
CC       regulating several biological processes including cell proliferation,
CC       apoptosis and differentiation (By similarity). Has a higher catalytic
CC       efficiency towards C12-ceramides versus other ceramides (By
CC       similarity). Also catalyzes the reverse reaction allowing the synthesis
CC       of ceramides from fatty acids and sphingosine (By similarity). For the
CC       reverse synthetic reaction, the natural sphingosine D-erythro isomer is
CC       more efficiently utilized as a substrate compared to D-erythro-
CC       dihydrosphingosine and D-erythro-phytosphingosine, while the fatty
CC       acids with chain lengths of 12 or 14 carbons are the most efficiently
CC       used (By similarity). Has also an N-acylethanolamine hydrolase activity
CC       (By similarity). By regulating the levels of ceramides, sphingosine and
CC       sphingosine-1-phosphate in the epidermis, mediates the calcium-induced
CC       differentiation of epidermal keratinocytes (By similarity). Also
CC       indirectly regulates tumor necrosis factor/TNF-induced apoptosis (By
CC       similarity). By regulating the intracellular balance between ceramides
CC       and sphingosine, in adrenocortical cells, probably also acts as a
CC       regulator of steroidogenesis (By similarity).
CC       {ECO:0000250|UniProtKB:Q13510}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acylsphing-4-enine + H2O = a fatty acid + sphing-4-enine;
CC         Xref=Rhea:RHEA:20856, ChEBI:CHEBI:15377, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:52639, ChEBI:CHEBI:57756; EC=3.5.1.23;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-dodecanoylsphing-4-enine = dodecanoate + sphing-4-
CC         enine; Xref=Rhea:RHEA:41291, ChEBI:CHEBI:15377, ChEBI:CHEBI:18262,
CC         ChEBI:CHEBI:57756, ChEBI:CHEBI:72956;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41292;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:41293;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-tetradecanoylsphing-4-enine = sphing-4-enine +
CC         tetradecanoate; Xref=Rhea:RHEA:41287, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:30807, ChEBI:CHEBI:57756, ChEBI:CHEBI:72957;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:41289;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-hexadecanoylsphing-4-enine = hexadecanoate + sphing-4-
CC         enine; Xref=Rhea:RHEA:38891, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57756, ChEBI:CHEBI:72959;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38892;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:38893;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-octadecanoylsphing-4-enine = octadecanoate + sphing-4-
CC         enine; Xref=Rhea:RHEA:41279, ChEBI:CHEBI:15377, ChEBI:CHEBI:25629,
CC         ChEBI:CHEBI:57756, ChEBI:CHEBI:72961;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41280;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:41281;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-dodecanoyl-(4R)-hydroxysphinganine = (4R)-
CC         hydroxysphinganine + dodecanoate; Xref=Rhea:RHEA:41303,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:18262, ChEBI:CHEBI:64124,
CC         ChEBI:CHEBI:78001; Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:41305;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(dodecanoyl)-sphinganine = dodecanoate + sphinganine;
CC         Xref=Rhea:RHEA:45448, ChEBI:CHEBI:15377, ChEBI:CHEBI:18262,
CC         ChEBI:CHEBI:57817, ChEBI:CHEBI:85261;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:45450;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(acetyl)-sphing-4-enine = acetate + sphing-4-enine;
CC         Xref=Rhea:RHEA:58484, ChEBI:CHEBI:15377, ChEBI:CHEBI:30089,
CC         ChEBI:CHEBI:46979, ChEBI:CHEBI:57756;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58485;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(hexanoyl)sphing-4-enine = hexanoate + sphing-4-enine;
CC         Xref=Rhea:RHEA:41295, ChEBI:CHEBI:15377, ChEBI:CHEBI:17120,
CC         ChEBI:CHEBI:57756, ChEBI:CHEBI:63867;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41296;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-octanoylsphing-4-enine = octanoate + sphing-4-enine;
CC         Xref=Rhea:RHEA:45092, ChEBI:CHEBI:15377, ChEBI:CHEBI:25646,
CC         ChEBI:CHEBI:45815, ChEBI:CHEBI:57756;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45093;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(9Z-octadecenoyl)-sphing-4-enine = (9Z)-octadecenoate
CC         + sphing-4-enine; Xref=Rhea:RHEA:41299, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:57756, ChEBI:CHEBI:77996;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41300;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-dodecanoylethanolamine = dodecanoate + ethanolamine;
CC         Xref=Rhea:RHEA:45456, ChEBI:CHEBI:15377, ChEBI:CHEBI:18262,
CC         ChEBI:CHEBI:57603, ChEBI:CHEBI:85263;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45457;
CC         Evidence={ECO:0000250|UniProtKB:Q13510};
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC       {ECO:0000250|UniProtKB:Q13510}.
CC   -!- SUBUNIT: Heterodimer; disulfide-linked. The heterodimer is composed of
CC       the disulfide-linked alpha and beta chains produced by autocatalytic
CC       cleavage of the precursor. {ECO:0000250|UniProtKB:Q13510}.
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000250|UniProtKB:Q13510}. Secreted
CC       {ECO:0000250|UniProtKB:Q13510}. Note=Secretion is extremely low and
CC       localization to lysosomes is mannose-6-phosphate receptor-dependent.
CC       {ECO:0000250|UniProtKB:Q13510}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q13510}.
CC   -!- PTM: Proteolytically cleaved into two chains alpha and beta that remain
CC       associated via a disulfide bond. Cleavage gives rise to a conformation
CC       change that activates the enzyme. The same catalytic Cys residue
CC       mediates the autoproteolytic cleavage and subsequent hydrolysis of
CC       lipid substrates. The beta chain may undergo an additional C-terminal
CC       processing. {ECO:0000250|UniProtKB:Q13510}.
CC   -!- SIMILARITY: Belongs to the acid ceramidase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB222170; BAF62415.1; -; mRNA.
DR   RefSeq; NP_001092030.1; NM_001098560.1.
DR   AlphaFoldDB; A5A6P2; -.
DR   SMR; A5A6P2; -.
DR   STRING; 9598.ENSPTRP00000034295; -.
DR   MEROPS; C89.001; -.
DR   PaxDb; A5A6P2; -.
DR   PRIDE; A5A6P2; -.
DR   Ensembl; ENSPTRT00000037110; ENSPTRP00000034295; ENSPTRG00000020027.
DR   GeneID; 464022; -.
DR   KEGG; ptr:464022; -.
DR   CTD; 427; -.
DR   VGNC; VGNC:53738; ASAH1.
DR   eggNOG; ENOG502QVBG; Eukaryota.
DR   GeneTree; ENSGT00530000063548; -.
DR   HOGENOM; CLU_054401_0_0_1; -.
DR   InParanoid; A5A6P2; -.
DR   TreeFam; TF313219; -.
DR   UniPathway; UPA00222; -.
DR   Proteomes; UP000002277; Chromosome 8.
DR   Bgee; ENSPTRG00000020027; Expressed in heart and 21 other tissues.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0005764; C:lysosome; ISS:UniProtKB.
DR   GO; GO:0102121; F:ceramidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0017064; F:fatty acid amide hydrolase activity; IEA:InterPro.
DR   GO; GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IBA:GO_Central.
DR   GO; GO:0017040; F:N-acylsphingosine amidohydrolase activity; ISS:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0046513; P:ceramide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0046514; P:ceramide catabolic process; ISS:UniProtKB.
DR   GO; GO:0006631; P:fatty acid metabolic process; IEA:InterPro.
DR   GO; GO:0030216; P:keratinocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0062098; P:regulation of programmed necrotic cell death; ISS:UniProtKB.
DR   GO; GO:0050810; P:regulation of steroid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0046512; P:sphingosine biosynthetic process; ISS:UniProtKB.
DR   InterPro; IPR016699; Acid_ceramidase-like.
DR   InterPro; IPR029130; Acid_ceramidase_N.
DR   InterPro; IPR029132; CBAH/NAAA_C.
DR   Pfam; PF02275; CBAH; 1.
DR   Pfam; PF15508; NAAA-beta; 1.
DR   PIRSF; PIRSF017632; Acid_ceramidase-like; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond; Glycoprotein; Hydrolase; Lipid metabolism; Lysosome;
KW   Reference proteome; Secreted; Signal; Sphingolipid metabolism; Zymogen.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..395
FT                   /note="Acid ceramidase"
FT                   /id="PRO_0000378101"
FT   CHAIN           22..142
FT                   /note="Acid ceramidase subunit alpha"
FT                   /evidence="ECO:0000250|UniProtKB:Q13510"
FT                   /id="PRO_0000446282"
FT   CHAIN           143..395
FT                   /note="Acid ceramidase subunit beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q13510"
FT                   /id="PRO_0000446283"
FT   ACT_SITE        143
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q13510"
FT   SITE            162
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q13510"
FT   SITE            320
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q13510"
FT   SITE            333
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q13510"
FT   CARBOHYD        195
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        259
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        286
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        342
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        31..340
FT                   /note="Interchain (between alpha and beta subunits)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13510"
FT   DISULFID        388..392
FT                   /evidence="ECO:0000250|UniProtKB:A0A0P6JG37"
SQ   SEQUENCE   395 AA;  44697 MW;  95F276721883EF4B CRC64;
     MPGRSRVALV LLAAAVSCAV AQHAPPWTED CRKSTYPPSG PTYRGPVPWY TINLDLPPYK
     RWHELMLDKA PMLKVIVNSL KNMINTFVPS GKIVQVVDEK LPGLLGNFPG PFEEEMKGIA
     AVTDIPLGEI ISFNIFYELF TICTSIVAED KKGHLIHGRN MDFGVFLGWN INNDTWVITE
     QLKPLTVNLD FQRNNKTVFK ASSFAGYVGM LTGFKPGLFS LSLNERFSIN GGYLGILEWI
     LGKKDAMWIG FLTRTVLENS TSYEEAKNLL TKTKILAPAY FILGGNQSGE GCVITRDRKE
     SLDVYELDAK QGRWYVVQTN YDRWKHPFFL DDRRTPAKMC LNRTSQENIS FETMYDVLST
     KPVLNKLTVY TTLIDVTKGQ FETYLRDCPD PCIGW
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024